About Us
Lantern Pharma uses artificial intelligence, machine learning, and genomics to develop cancer therapies and improve the drug development process. Its RADR platform analyzes clinical, genomic, molecular, and drug response data to identify biomarkers, predict patient responses, evaluate drug combinations, and guide clinical trial design. The company develops targeted therapies across multiple cancer indications.
Related Articles